The Times Australia
Fisher and Paykel Appliances
The Times News

.

Morrison wrong to try to influence advice from expert immunisation group

  • Written by Michelle Grattan, Professorial Fellow, University of Canberra

Scott Morrison this week more or less trashed Australia’s top advisory body on immunisation, in remarks that were at best ill-judged and at worst alarming.

On Wednesday Morrison told a news conference he (or the government) made a “constant appeal” to the Australian Technical Advisory Group on Immunisation (ATAGI) to review its advice on AstraZeneca according to the balance of risk.

On Thursday he said on radio: “I’ve just simply said balance of risk is changing, guys, so how is that impacting on your advice, and it’s time to think about that”.

The “guys” (and girls) on ATAGI are obviously as aware as anyone of the changing risk profile as cases increase.

Indeed ATAGI has already altered its advice on AstraZeneca in light of the Sydney outbreak. On July 13 it said where there was an outbreak and the Pfizer supply was constrained, people under 60 without immediate access to Pfizer should “reassess the benefits to them and their contacts from being vaccinated with COVID-19 Vaccine AstraZeneca, versus the rare risk of a serious side effect”.

ATAGI, whose members have qualifications in immunisation and infectious diseases, is charged with advising the health minister on immunisation issues.

There’s no doubt its advice on AstraZeneca has been very cautious. It threw a spanner in the vaccination works when it said that Pfizer (of which Australia doesn’t yet have enough) was preferred for those under 50, and then raised the age to under 60.

This was based on the very small risk of blood clots, which are more likely to occur in younger people. Two more recent deaths associating AZ and clots were announced by the Therapeutic Goods Administration on Thursday – the people were in their 40s.

Whether ATAGI is right or wrong in its caution is disputed.

Read more: Is the COVID vaccine rollout the greatest public policy failure in recent Australian history?[1]

But it is not the only expert source in Australia taking this position. A paper by the Kirby Institute’s Raina MacIntyre and other authors published in this month’s issue of the international journal Vaccine[2] reported their “risk-benefit analysis for Australians aged 18–59”, comparing the risk of AZ vaccination with the risk of COVID infection.

The authors concluded: “In Australia, the potential risks of the AZD1222 vaccine in younger adults, who are at low risk of dying from COVID-19, may outweigh the benefits”.

The article also said: “The latest policy decision to avoid use of this vaccine in adults < 60 years in Australia is entirely consistent with past vaccine risk–benefit policy decisions when rare but serious adverse events were identified”.

The authors say their analysis, done after the death of a 48-year-old woman, was “shared with senior health officials in Australia on April 8, 2021”. That was the same day ATAGI advised against AZ for under 50s, with the government announcing this at a hastily-called night news conference.

It’s up to the government whether it accepts whatever ATAGI says – as ATAGI’s remit indicates, it only “advises”.

Certainly we know ATAGI’s advice (and the debate it prompted) contributed to vaccine hesitancy including among those for whom AZ is most appropriate – older people – and this is very unfortunate.

It would be legitimate – if difficult and some would say irresponsible – for Morrison at any point to say he thought ATAGI wrong, that other advisers were telling him something else, and so the government rejected ATAGI’s advice.

But what he – a leader with his back against the wall because of the Pfizer shortage and the rollout shambles – should not do is try to lean on a supposedly independent expert group to change its advice.

The PM’s aim seemed obvious. If ATAGI was pliable, he could say, “this is the new health advice – everyone should follow it”. He would have the best of all worlds.

Or perhaps not. If and when ATAGI changes its advice from now on – even if the PM’s view has nothing to do with that change – will it have the same credibility? Won’t many people, already suspicious and cynical, think: that’s just ATAGI giving into political pressure?

If the perception of ATAGI’s independence is going to be undermined, the usefulness of the body – whatever it says – becomes questionable.

At his Thursday news conference, Morrison tried to re-spin his pressure on ATAGI. He completely respected its advice, he said. “That’s why we’ve followed the advice of ATAGI. It’s my job as prime minister not just to simply accept advice uncritically. Whether it’s sitting in cabinet meetings or in other forums, of course I challenge the advice that I receive. I ask questions. I drill into it. You would expect me to do that. I think Australians would not expect me to just take this advice simply on the face of it.”

Actually, on numerous occasions, the government has made a virtue of just accepting health advice without question.

In the Australian Financial Review[3] two economists, Ashley Craig and Matthew Lilley, have criticised ATAGI for not building into its recommendations social benefits versus risks.

They write: “ask yourself whether ATAGI made the right call by refusing to properly account for social benefits in its advice, which encouraged millions of Australians to delay vaccination”.

“It is not too late to change this message. With millions stuck in lockdowns, ATAGI could instead be emphasising how accelerating vaccinations will make society better off.”

This, however, seems wrong-headed. ATAGI is a narrow, specialist vaccination advisory body. You wouldn’t ask Treasury to assess the effectiveness of Pfizer against AstraZeneca. ATAGI’s advice is part of a wider picture, which government has the job of bringing together into one frame.

The ATAGI episode is just the latest chapter in the evolving story of the role of health experts in this pandemic.

Early on, their status was substantially unquestioned. Morrison and other leaders constantly referred and deferred to them.

But then health officials especially at state level became controversial figures, accused of being political.

Although the federal bureaucrats have not been targets in the same way as state officials, there has been a growing perception their advice is influenced by the political needs of their masters.

This makes it all the more important that independent advisory groups like ATAGI are not perceived as having a political tinge.

As Morrison struggled with what he was saying, or not saying, about ATAGI, on Thursday he did what he hates doing, to get the media off his back on another front.

Read more: View from The Hill: Morrison and Coalition sink in Newspoll on the back of rollout shambles[4]

He had been under pressure for earlier refusing to say “sorry” for the rollout problems – he’d resisted the word, preferring to say he took responsibility.

But at Thursday’s news conference he said: “I’m certainly sorry that we haven’t been able to achieve the marks that we had hoped for at the beginning of this year. Of course I am.”

He had decided, or been persuaded, that the “sorry” question wouldn’t go away without being dealt with. It might be harder to put the ATAGI questions to rest.

Read more https://theconversation.com/grattan-on-friday-morrison-wrong-to-try-to-influence-advice-from-expert-immunisation-group-164966

Times Magazine

Can bigger-is-better ‘scaling laws’ keep AI improving forever? History says we can’t be too sure

OpenAI chief executive Sam Altman – perhaps the most prominent face of the artificial intellig...

A backlash against AI imagery in ads may have begun as brands promote ‘human-made’

In a wave of new ads, brands like Heineken, Polaroid and Cadbury have started hating on artifici...

Home batteries now four times the size as new installers enter the market

Australians are investing in larger home battery set ups than ever before with data showing the ...

Q&A with Freya Alexander – the young artist transforming co-working spaces into creative galleries

As the current Artist in Residence at Hub Australia, Freya Alexander is bringing colour and creativi...

This Christmas, Give the Navman Gift That Never Stops Giving – Safety

Protect your loved one’s drives with a Navman Dash Cam.  This Christmas don’t just give – prote...

Yoto now available in Kmart and The Memo, bringing screen-free storytelling to Australian families

Yoto, the kids’ audio platform inspiring creativity and imagination around the world, has launched i...

The Times Features

The rise of chatbot therapists: Why AI cannot replace human care

Some are dubbing AI as the fourth industrial revolution, with the sweeping changes it is propellin...

Australians Can Now Experience The World of Wicked Across Universal Studios Singapore and Resorts World Sentosa

This holiday season, Resorts World Sentosa (RWS), in partnership with Universal Pictures, Sentosa ...

Mineral vs chemical sunscreens? Science shows the difference is smaller than you think

“Mineral-only” sunscreens are making huge inroads[1] into the sunscreen market, driven by fears of “...

Here’s what new debt-to-income home loan caps mean for banks and borrowers

For the first time ever, the Australian banking regulator has announced it will impose new debt-...

Why the Mortgage Industry Needs More Women (And What We're Actually Doing About It)

I've been in fintech and the mortgage industry for about a year and a half now. My background is i...

Inflation jumps in October, adding to pressure on government to make budget savings

Annual inflation rose[1] to a 16-month high of 3.8% in October, adding to pressure on the govern...

Transforming Addiction Treatment Marketing Across Australasia & Southeast Asia

In a competitive and highly regulated space like addiction treatment, standing out online is no sm...

Aiper Scuba X1 Robotic Pool Cleaner Review: Powerful Cleaning, Smart Design

If you’re anything like me, the dream is a pool that always looks swimmable without you having to ha...

YepAI Emerges as AI Dark Horse, Launches V3 SuperAgent to Revolutionize E-commerce

November 24, 2025 – YepAI today announced the launch of its V3 SuperAgent, an enhanced AI platf...